90291111
Oct 30, 2020
Sep 6, 2022
Active Trademark
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, COVID-19; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of antibodies; all of the foregoing related to the detection of COVID-19
Pharmaceuticals